Context Therapeutics Inc. — Investor Relations & Filings
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to advancing treatments for solid tumors. The company develops next-generation T cell engaging (TCE) bispecific antibody therapies designed to harness the patient's immune system for targeted cancer eradication. Its pipeline features innovative immunotherapeutic solutions for difficult-to-treat solid tumors. Key portfolio highlights include CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody; CT-95, an avidity-enhanced mesothelin (MSLN) x CD3 bispecific antibody; and CT-202, a dual pH-dependent Nectin-4 x CD3 bispecific antibody.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| ARS - Context Therapeutics Inc. (0001842952) (Filer) | 2026-04-28 | English | |
| 8-K - Context Therapeutics Inc. (0001842952) (Filer) | 2026-04-02 | English | |
| S-8 - Context Therapeutics Inc. (0001842952) (Filer) | 2026-03-23 | English | |
| 8-K - CONTEXT THERAPEUTICS INC. (0001842952) (Filer) | 2026-02-27 | English | |
| 4 - CONTEXT THERAPEUTICS INC. (0001842952) (Filer) | 2026-02-23 | English |
Browse filings by year
6 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Chemomab Therapeutics Ltd.
Clinical-stage biotech developing therapeutics for fibro-in…
|
CMMB | US | Manufacturing |
|
ChengDa Pharmaceuticals Co.,Ltd.
Global supplier of APIs and intermediates, specializing in …
|
301201 | CN | Manufacturing |
|
Chengdu Easton Bio Pharmaceuticals Co.,Ltd
Develops and manufactures chemical APIs and finished dosage…
|
688513 | CN | Manufacturing |
|
Chengdu huasun technology group Inc., Ltd
Develops and produces pharmaceuticals, biotech, and moderni…
|
000790 | CN | Manufacturing |
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
Develops innovative drugs and devices for ophthalmology, CN…
|
002773 | CN | Manufacturing |
|
Chengdu Kanghua Biological Products Co., Ltd.
Develops and produces human vaccines, including rabies and …
|
300841 | CN | Manufacturing |
|
Chengdu Olymvax Biopharmaceuticals Inc.
Researches, develops, and manufactures human vaccines to pr…
|
688319 | CN | Manufacturing |
|
CHENGDU SHENG NUO BIOTEC CO.,LTD.
Specialized in peptide drug R&D, manufacturing, and integra…
|
688117 | CN | Manufacturing |
|
Chia Tai Enterprises International Limited
Leading global producer of chlortetracycline (CTC) and enga…
|
3839 | HK | Manufacturing |
|
Chimin Health Management Co., Ltd.
Produces medical devices, pharmaceuticals, and safety-engin…
|
603222 | CN | Manufacturing |
Context Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34269/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34269 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34269 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34269 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34269}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Context Therapeutics Inc. (id: 34269)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.